-
Corrigendum to “The effect of Bruton's tyrosine kinase inhibitor ibrutinib on atherothrombus formation under stenotic flow conditions” [Thromb. Res. 212 (2022) 72–80] (Thrombosis Research (2022) 212 (72–80), (S0049384822000640), (10.1016/j.thromres.2022.02.020))
Karel, M. F. A., Tullemans, B. M. E., D'Italia, G., Lemmens, T. P., Claushuis, T. A. M., Kuijpers, M. J. E. & Cosemans, J. M. E. M., May 2022, In: Thrombosis research. 213, p. 113 1 p.Research output: Contribution to journal › Comment/Letter to the editor* › Academic
-
The effect of Bruton's tyrosine kinase inhibitor ibrutinib on atherothrombus formation under stenotic flow conditions
Karel, M. F. A., Tullemans, B. M. E., D'Italia, G., Lemmens, T. P., Claushuis, T. A. M., Kuijpers, M. J. E. & Cosemans, J. M. E. M., Apr 2022, In: Thrombosis research. 212, p. 72-80 9 p.Research output: Contribution to journal › Article* › Academic › peer-review
-
Nutrition Phytochemicals Affecting Platelet Signaling and Responsiveness: Implications for Thrombosis and Hemostasis
Tamer, F., Tullemans, B. M. E., Kuijpers, M. J. E., Claushuis, T. A. M. & Heemskerk, J. W. M., 29 Dec 2021, In: Thrombosis and Haemostasis. 122, 6, p. 879-894 16 p.Research output: Contribution to journal › Review article* › Academic › peer-review
- All publications
